Clear Street analyst Brian Dobson upgraded Core Scientific (CORZ) to Buy from Hold with a price target of $23, up from $14, ahead of Thursday’s shareholder vote. Given the strong stock performance within the peer group, the firm sees it as “increasingly likely” that shareholders vote down the proposed acquisition or that CoreWeave (CRWV) increases its offer, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Core Scientific Reports Q3 2025 Financial Results
- Core Scientific Reports Q3 2025 Revenue Decline
- Core Scientific reports Q3 EPS (46c) vs ($1.17) last year
- Crypto Currents: Coinbase acquires capital raising platform Echo
- Core Scientific price target raised to $26 from $18 at Cantor Fitzgerald
